BioLert Electro Medical Systems is dedicated to the development and manufacture of medical devices for the monitoring of vital signs. The companys first product line is targeted to the epilepsy market.
BioLert is developing a new electro-medical device to support a remote monitoring solution for patients and their caregivers. The device combines smartwatch technology, a smartphone, and a patented algorithm to continuously monitor for and detect seizure events.
The companys patented and proven technology is designed to increase independence and self-confidence in people suffering from seizures. Users can be assured that regardless of their location, in the event of a severe nervous system event their specified contacts will be notified.
Cumulative Funding Raised Over Time ($)
Employees Over Time
BioLert Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 28, 2019
www.businesswire.com
Healthcare Cloud Computing Market Is Witnessed to Grow USD 16.37 Billion, at 22% CAGR from 2018-2022 Technavio